Skip to main content
Have a personal or library account? Click to login
Adipocyte “Fatty Acid Binding Protein” Gene Polymorphisms (rs1054135, rs16909196 and rs16909187) in Jordanians with Obesity and Type 2 Diabetes Mellitus Cover

Adipocyte “Fatty Acid Binding Protein” Gene Polymorphisms (rs1054135, rs16909196 and rs16909187) in Jordanians with Obesity and Type 2 Diabetes Mellitus

Open Access
|May 2023

Figures & Tables

Table 1.

Demographic and clinical laboratory characteristics of subjects enrolled in the study.

CharacteristicGroup 1 (Obese or overweight diabetics) (n=98)Group 2 (Diabetics with normal weight) (n=103)Group 3 (Nondiabetic but overweight or obese) (n=102)Group 4 (Normal weight and nondiabetics) (n=94)p-value
Mean age ± SDa (years)57.6 ± 9.852.5 ±16.147.8 ± 12.434.5 ± 14.80.00b
GenderMale466483590.00c
Female52391935
Mean TG ± SD (mg/dL)184.7 ± 158.9174.5 ± 136.0223.05 ± 184.1110.1 ± 66.10.00b
Mean TC ± SD (mg/dL)187.3 ± 43.3189.1 ± 44.6197.6 ± 36.8181.9 ± 44.40.00b
Mean LDL ± SD (mg/dL)123.3 ± 36.4121.8 ± 37.8128.5 ± 33.8108.2 ± 36.20.00b
Mean HDL ± SD (mg/dL)43.5 ± 12.345.6 ± 19.439.3 ± 13.844.6 ± 11.40.016b
Mean HbA1C ± SD (%)8.8 ± 8.87.8 ± 2.15.07 ± 0.394.8 ± 0.440.00b
Mean BMI ± SD (Kg/m2)33.8 ± 6.522.1 ± 2.131.3 ± 4.621.5 ± 2.090.00b

{ label (or @symbol) needed for fn[@id='j_bjmg-2022-0019_t1fn1'] } TG (triglycerides), TC (total cholesterol), LDL (low density lipoprotein), HDL (high density lipoprotein), HBA1C (hemoglobin A1C), BMI (body mass index), m (height in meters),

{ label (or @symbol) needed for fn[@id='j_bjmg-2022-0019_t1fn2'] } SDa (standard deviation),

b (ANOVA test),

c (Pearson Chi-square test).

Table 2.

Genotypes and allele frequencies of rs1054135, rs16909196 and rs16909187 SNPs among all groups combined.

rs1054135
GenotypeNumber of subjectsFrequency
Homozygous major alleleGG3480.877
HeterozygousGA440.111
Homozygous minor alleleAA50.013
Total3971.0
AlleleNumber of copiesFrequency
G7400.932
A540.068
Total7941.0
rs16909196
GenotypeNumber of subjectsFrequency
Homozygous major alleleAA2590.652
HeterozygousAT1160.292
Homozygous minor alleleTT220.055
Total3971.0
AlleleNumber of copiesFrequency
A6340.798
T1600.202
Total7941.0
rs16909187
GenotypeNumber of subjectsFrequency
Homozygous major alleleCC2610.657
HeterozygousCT1140.287
Homozygous minor alleleTT220.055
Total3971.0
AlleleNumber of copiesFrequency
C6360.801
T1580.199
Total794
Table 3.

Assessment of the Hardy-Weinberg equilibrium of the three SNPs in the study sample as a whole and in the control group (group 4) alone.

SNPGenotypesThe whole studied group (n=397)X* parameterControl group (n=94)X* parameter
ObservedExpectedObservedExpected
rs1054135GG0.87700.8687- 3.82450.84000.8263- 3.8140
GA0.11100.12760.13800.1654
AA0.01300.00470.02200.0083
rs16909196AA0.65200.6374- 3.83330.57400.5700- 3.8410
AT0.29200.32110.36200.3670
TT0.05500.04040.06400.0600
rs16909187CC0.65700.6414- 3.83190.56400.5625- 3.8414
CT0.28700.31810.37200.3750
TT0.05500.03940.0640.0625

* According to the online calculator used, when X is greater than or equal to zero, then there are significant changes between the observed and expected genotype frequencies, and the genotypes are not in Hardy-Weinberg equilibrium.

Table 4:

Genotype distribution of FABP4 SNPs rs1054135, rs16909196, and rs16909187 among the four study groups.

SNPs rs1054135rs16909196rs16909187
Genotypes GGGAAAAAATTTCCCTTT
Group 1 n=9888826229763287
Group 2 n=103901216828768287
Group 3 n=102911107624276242
Group 4 n=94791325335654346
Groups 1 vs 4Z score1.1761.2450.0420.9721.1230.210.9711.1240.210
P value0.240.210.970.330.260.830.330.20.83
Odds ratio1.67
(0.71-3.93)
0.55
(0.22-1.40)
0.96
(0.13-6.95)
1.33
(0.75-2.38)
0.71
(0.39-1.29)
1.13
(0.36-3.49)
1.33
(0.75-2.38)
0.71
(0.38-1.30)
1.13
(0.36-3.49)
Groups 2 vs 4Z score0.6680.4580.6461.3851.5060.1171.2361.3530.117
P value0.500.650.520.170.130.910.220.180.91
Odds ratio1.31
(0.59-2.93)
0.82
(0.36-1.90
0.45
(0.04-5.06)
1.5
(0.84-2.68)
0.63
(0.34-1.15)
1.07
(0.35-3.3)
1.44
(0.81-2.56)
0.66
(0.36-1.20)
1.07
(0.35-3.30)
Groups 3 vs 4Z score1.0610.6501.1002.6492.0801.4792.5051.9261.479
P value0.290.520.270.010.040.140.010.050.14
Odds ratio1.57
(0.68-3.62)
0.75
(0.32-1.77)
0.18
(0.01-3.81)
2.26
(1.24-4.14)
0.52
(0.28-0.96)
0.29
(0.06-1.49)
2.17
(1.18-3.96)
0.54
(0.29-1.01)
0.29
(0.06-1.49)
Table 5.

Comparison of (rs1054135, rs16909196, and rs16909187) haplotypes between control group and other groups.

rs1054135, rs16909196, and rs16909187 haplotypesGACGTTAAC
Group 1 (Obese or overweight diabetics)0.7320.2020.049
Group 2 (Diabetics with normal weight)0.7230.1990.068
Group 3 (Non-diabetic but overweight or obese)0.8090.1370.054
Group 4 (Control) (Normal weight nondiabetics)0.6600.2450.090
Groups 1 vs 4z score1.085-0.716-1.12
p value0.280.470.26
Groups 2 vs 4z score0.958-0.777-0.574
p value0.340.440.57
Groups 3 vs 4z score2.369-1.93-0.979
p value0.020.050.33
Table 6.

Linkage disequilibrium of FABP4 genetic variants (rs1054135, rs16909187, and rs16909196) in the four study groups using the Haploview program.

Study GroupFABP4 Gene VariantsD′ (Linkage disequilibrium parameter)R2 (Correlation Coefficient)
Group 1:
(Obese or overweight diabetics)
rs1054135 and rs169091870.0460.0
rs1054135 and rs169091960.0840.0
rs16909187 and rs169091961.00.97
Group 2:
(Diabetics with normal weight)
rs1054135 and rs169091871.00.019
rs1054135 and rs169091961.00.019
rs16909187 and rs169091960.970.94
Group 3:
Nondiabetic but overweight or obese)
rs1054135 and rs169091871.00.009
rs1054135 and rs169091961.00.009
rs16909187 and rs169091961.01.0
Group 4:
(Control) (Normal weight nondiabetics)
rs1054135 and rs169091871.00.03
rs1054135 and rs169091961.00.03
rs16909187 and rs169091961.00.97
DOI: https://doi.org/10.2478/bjmg-2022-0019 | Journal eISSN: 2199-5761 (formerly 1311-0160) | Journal ISSN: 1311-0160
Language: English
Page range: 63 - 70
Published on: May 2, 2023
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services

© 2023 S.W. El-Ryalat, Y.M. Irshaid, M. Abujbara, M. El-Khateeb, K.M. Ajlouni, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.